abstract |
Formulations comprising both benzodiazepine antibody-drug conjugate (ADC) and cyclodextrin are disclosed, including both liquid and lyophilized formulations. Also disclosed are methods for purifying a mixture comprising a benzodiazepine antibody-drug conjugate and treated drug-related impurities. |